Breaking Research News from Breastcancer.org
Comments
-
Tibetan Yoga May Help Women Being Treated With Chemotherapy Sleep Better
September 26, 2017
A small study suggests that practicing Tibetan yoga twice a week may improve sleep in women being treated with chemotherapy for breast cancer. Read more...0 -
FDA Approves Verzenio to Treat Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer
September 28, 2017
Verzenio has been approved by the FDA. Read more...0 -
Cryotherapy May Help Prevent Neuropathy Caused by Taxol Chemotherapy
October 13, 2017
A small study suggests that wearing frozen gloves and socks for 90 minutes after Taxol chemotherapy can help control neuropathy symptoms. Read more...0 -
2017 Breast Cancer Statistics Show Survival Rates Improving
October 17, 2017
A new American Cancer Society report says that the number of women who died from breast cancer dropped about 40% in the past 25 years, which translates into more than 322,000 lives saved during that time period. Read more...0 -
Study Looks at Lymphedema Risk Factors
October 17, 2017
A study looked at a number of potential lifestyle and clinical risk factors for lymphedema and assessed the relationship between the risk factors and developing lymphedema. Read more...0 -
More Women Having Reconstruction After Mastectomy
October 19, 2017
Rates of breast reconstruction after mastectomy rose 62% from 2009 to 2014. Read more...0 -
Long-Term Use of Insulin Glargine May Be Linked to Higher Risk of Breast Cancer
October 19, 2017
Women with type 2 diabetes treated long-term with insulin glargine may have a higher risk of breast cancer. Read more...0 -
Health Care Professional's Recommendation Most Important Factor in Whether Women Take Hormonal Therapy Preventively
October 20, 2017
A health care professional's recommendation is the most important factor affecting decisions by women at high risk for breast cancer on whether to take preventive hormonal therapy. Read more...0 -
Study Suggests Link Between Exposure to Chemicals Early in Life and Breast Cancer Risk
October 23, 2017
A study suggests that exposure to certain chemicals in the environment, especially early in life, is linked to a higher risk of breast cancer. Read more...0 -
Study Finds 72 New Genetic Mutations Linked to Breast Cancer
October 24, 2017
Researchers have discovered 72 new genetic variants associated with a higher risk of breast cancer. Read more...0 -
So what does this mean for those of us who have already been tested? I was just tested in late August and was BRACA negative. There is a strong run of BC in my family and now I’m curious if one of those new mutations found are “ours”. None of my family members who have been tested have ever had a positive result.
0 -
Minority Women Less Likely to Have Immediate Breast Reconstruction
November 1, 2017
White women are 24% more likely to have immediate reconstruction than black women; 26% more likely than Asian, Pacific Islander, and Native American women; and 19% more likely than Hispanic women. Read more...0 -
ASCO Releases Statement on Alcohol and Cancer Risk
November 9, 2017
To bring attention to the links between alcohol and cancer, the American Society of Clinical Oncology has taken a position on alcohol and cancer risk for the first time. Read more...0 -
Distant Recurrence Risk of Hormone-Receptor-Positive Breast Cancer Steady 20 Years After Initial Diagnosis
November 13, 2017
After 5 years of hormonal therapy, the risk of distant recurrence is still sizable, even 20 years after the initial diagnosis, and the risk of distant recurrence is strongly linked to cancer size and number of positive lymph nodes. Read more...0 -
Cymbalta Eases Joint Pain From Aromatase Inhibitors
November 16, 2017
The antidepressant Cymbalta can help ease joint pain caused by aromatase inhibitors. Read more...0 -
Intratumoral Injection of c-Met CAR T Cells in Metastatic Breast Cancer
http://www.practiceupdate.com/c/60815/67/13/?elsca...
In patients with metastatic breast cancer, intratumoral injections of mRNA c-Met-CAR T cells evoked a tumor-specific inflammatory response and were well-tolerated.
0 -
Overweight Women Likely to Have Larger Breast Cancers at Diagnosis, May Need More Frequent Screening
November 22, 2017
A Swedish study suggests that besides having a higher risk of breast cancer, overweight and obese women are more likely to have larger breast cancer tumors at diagnosis, which may mean that overweight and obese women should have more frequent screening so the cancers can be found when they are smaller. Read more...0 -
Women Prefer to Get Mammograms Every Year
November 28, 2017
A small study suggests that women prefer to have mammograms every year instead of every 2 years because the benefits of annual screening outweigh any potential risks. Read more...0 -
FDA Approves Herceptin Biosimilar
December 1, 2017
The FDA has approved Ogivri, a biosimilar to Herceptin, to treat HER2-positive breast cancer. Read more...0 -
Do Hormonal Contraceptives Increase Breast Cancer Risk?
December 13, 2017
Hormonal contraceptives slightly increase the risk of breast cancer. But the importance of the increase is unique to each woman and depends on many factors. Read more...0 -
Overweight Postmenopausal Women Who Lose Modest Amount of Weight Have Lower Breast Cancer Risk
December 16, 2017
Overweight postmenopausal women who lost about 5% of their body weight -- about 10 pounds on average -- had a lower risk of breast cancer compared to women who didn't lose weight. Read more...0 -
Kisqali Can Help Treat Younger Women With Metastatic Hormone-Receptor-Positive Disease
December 19, 2017
Kisqali along with either an aromatase inhibitor or tamoxifen and medicine to suppress ovarian function offers better progression-free survival than just hormonal therapy and ovarian suppression in premenopausal women with advanced-stage, hormone-receptor-positive, HER2-negative disease. Read more...0 -
Experimental Talazoparib Seems Better Than Chemotherapy for Metastatic HER2-Negative Disease in Women With a BRCA Mutation
December 20, 2017
The targeted therapy talazoparib resulted in longer progression-free survival compared to chemotherapy in women with a BRCA1 or BRCA2 mutation diagnosed with metastatic HER2-negative breast cancer. Read more...0 -
Acupuncture Eases Joint Pain Caused by Aromatase Inhibitors
December 21, 2017
The largest study done to date found that acupuncture relieves aromatase inhibitor-caused joint pain. Read more...0 -
Temporary Ovarian Suppression May Help Preserve Fertility During Chemotherapy
January 2, 2018
A meta-analysis suggests that premenopausal women diagnosed with early-stage breast cancer who are treated with gonadotropin-releasing hormone analog during chemotherapy are more likely to have their periods return after treatment ends and may be more likely to have children after breast cancer treatment. Read more...0 -
Extending Aromatase Inhibitor Treatment for 5 More Years No Better Than 2 More Years
January 3, 2018
A study has found that taking Arimidex for an extra 5 years -- for a total of 10 years of hormonal therapy -- offers no more benefits than taking Arimidex for an extra 2 years. Read more...0 -
Younger Women Report High Rate of Arm Problems 1 Year After Breast Cancer Diagnosis
January 4, 2018
Up to 40% of younger women say they have arm problems 1 year after being diagnosed with breast cancer. Read more...0 -
Very Early Study Hints That Keytruda May Offer Benefits for Certain Metastatic HER2-Positive Breast Cancers
January 9, 2018
A very small, very early study hints that the immunotherapy medicine Keytruda may offer benefits for certain metastatic HER2-positive breast cancers. Read more...0 -
Study Suggests Intensifying Chemotherapy Improves Outcomes for Women With Early-Stage Disease
January 10, 2018
Dose-intensified chemotherapy regimens seem to decrease the risk of recurrence as well as the risk of dying from breast cancer in women diagnosed with early-stage disease. Read more...0 -
Combo of Tykerb, Herceptin, and Aromatase Inhibitor Seems Best for Metastatic, HER2-Positive, Hormone-Receptor-Positive Disease
January 12, 2018
The combination of Tykerb, Herceptin, and an aromatase inhibitor seems better than just Herceptin and an aromatase inhibitor or just Tykerb and an aromatase inhibitor for treating metastatic HER2-positive, hormone-receptor-positive breast cancer in postmenopausal women. Read more...0
